Sorrento Therapeutics Announces Discovery Of A Potential Non-Dopaminergic Approach To Controlling Parkinson's Motor Symptoms With Resiniferatoxin Intrathecal Administration, Announces 'Positive And Better Than Initially Hoped For' Top Line Results
Benzinga Newsdesk